Medicine & Life Sciences
Bipolar Disorder
100%
Mesenchymal Stem Cells
92%
Chile
83%
Inflammatory Bowel Diseases
57%
Pregnancy
44%
Therapeutics
39%
Fecal Microbiota Transplantation
37%
Pre-Eclampsia
28%
Cell- and Tissue-Based Therapy
25%
Rheumatoid Arthritis
23%
Biomarkers
22%
Systemic Lupus Erythematosus
20%
T-Lymphocytes
20%
Mothers
19%
Population
19%
Irritable Bowel Syndrome
19%
Ankle
18%
Ulcerative Colitis
18%
Phenotype
18%
SARS Virus
18%
Safety
17%
Immunosuppressive Agents
17%
Pregnant Women
17%
Th17 Cells
16%
Stem Cells
16%
Induced Labor
15%
Osteoporosis
15%
Infections
15%
Rheumatic Heart Disease
14%
Gingival Crevicular Fluid
14%
Comorbidity
14%
Natural Family Planning Methods
14%
Regulatory T-Lymphocytes
14%
Nurses
14%
Autoimmune Experimental Encephalomyelitis
14%
Fetal Growth Retardation
13%
Frailty
13%
Pharmacogenetics
13%
Cross-Sectional Studies
13%
Rupture
13%
Misoprostol
13%
Gestational Age
13%
Rheumatic Fever
13%
Guidelines
13%
Neoplasms
13%
Osteotomy
13%
Metatarsal Bones
13%
Quality of Life
13%
Umbilical Cord
12%
Crohn Disease
12%
Prenatal Diagnosis
12%
Gestational Diabetes
12%
Interleukin-1
12%
Myocardial Infarction
12%
Gastrointestinal Diseases
11%
Advisory Committees
11%
Cardiovascular Diseases
11%
Presbycusis
11%
Workforce
11%
First Pregnancy Trimester
11%
Neuropilin-1
11%
Th1 Cells
11%
Foot
11%
Case-Control Studies
11%
Autoimmune Diseases
10%
Echocardiography
10%
Randomized Controlled Trials
10%
Osteoporotic Fractures
10%
Vaccines
10%
Depression
10%
Clostridium Infections
10%
Pharmaceutical Preparations
10%
Health
10%
Genitalia
10%
Mortality
10%
Addison Disease
10%
Cohort Studies
10%
Confidence Intervals
10%
Systematic Reviews
10%
Exosomes
9%
Anemia
9%
Biopsy
9%
Dinoprostone
9%
Cryptococcosis
9%
Colonoscopy
9%
Decision Making
9%
Antidepressive Agents
9%
Gastrointestinal Microbiome
9%
Anti-Inflammatory Agents
9%
Placenta
9%
Psychotic Disorders
9%
Odds Ratio
8%
Connective Tissue Diseases
8%
Public Hospitals
8%
Pseudoatrophoderma Colli
8%
Injections
8%
Ankle Injuries
8%
Endocrinology
8%
Brain
8%
tofacitinib
8%